Acquisitions /Mergers/Joint-ventures October 16, 2014  Biotech, pharma and medtech see strong M&A activity A report from Mergermarket found that the medtech, biotech and pharma industries had already made 869 merger and acquisition deals in 2014 totaling $354.3 billion– the most since 2001. The report also forecasts that strong M&A activity will likely […]

    Acquisitions /Mergers/Joint-ventures October 16, 2014  AbbVie stops its plans to acquire Shire  The company said it was recommending shareholders to vote against the $54 billion takeover deal it had signed on July 18 in light of new tax rules from the U.S. Treasury Department. “Although the strategic rationale of combining our two companies […]

  You could find new customers or partners at  the following events but you lake time to take part:  CPhI /ICSE 7-9 October 2014, Paris.  (Pharma/ Biotech / Company providing outsourced services)   JIB,8-10 October 2014, Paris. (French & European Diagnostic)   Bio-Europe, Franckfurt 3-5 November, Franckfurt. (Pharma/ Biotech, Company providing outsourced services)   Biofit, 2-3 […]

Biopharmaceutical NewsWeek 41        Acquisitions /Mergers/Joint-ventures October 5, 2014  Becton Dickinson acquires Care Fusion for $12.2B Becton Dickinson announced that it will acquire CareFusion for $12.2 billion to broaden its offerings to hospitals. Vincent Forlenza, the CEO of BD, said the “acquisition will help the company address unmet needs in the growing $20 […]

Biopharmaceutical NewsWeek # 40 Acquisitions /Mergers/Joint-ventures September 29, 2014  Daiichi Sankyo agreed to buy Ambit Biosciences Daiichi Sankyo agreed to buy Ambit Biosciences, a US-based company, for $410 million and thus hopes to increase its pipeline of cancer treatments. The Japanese company will pay $15 in cash per share. Ambit shareholders will have the right […]